Radiotherapy and PD-L1 inhibition in metastatic NSCLC

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Keywords

@article{82700439b0684618b8d950c62b73fccf,

title = "Radiotherapy and PD-L1 inhibition in metastatic NSCLC",

keywords = "CELL LUNG-CANCER, IMMUNOTHERAPY, MECHANISMS, RADIATION, THERAPY",

author = "{De Ruysscher}, Dirk",

year = "2017",

month = jul,

doi = "10.1016/S1470-2045(17)30354-6",

language = "English",

volume = "18",

pages = "840--842",

journal = "Lancet oncology",

issn = "1470-2045",

publisher = "The Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - Radiotherapy and PD-L1 inhibition in metastatic NSCLC

AU - De Ruysscher, Dirk

PY - 2017/7

Y1 - 2017/7

KW - CELL LUNG-CANCER

KW - IMMUNOTHERAPY

KW - MECHANISMS

KW - RADIATION

KW - THERAPY

U2 - 10.1016/S1470-2045(17)30354-6

DO - 10.1016/S1470-2045(17)30354-6

M3 - Editorial

SN - 1470-2045

VL - 18

SP - 840

EP - 842

JO - Lancet oncology

JF - Lancet oncology

IS - 7

ER -